Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/2/2025

Therapeutic Management of Hospitalized Patients with Major Depressive Disorder and Suicidal Ideations

Introduction to Management

  • The American College of Physicians recommends initiating a second-generation antidepressant, such as an SSRI or SNRI, for hospitalized patients with Major Depressive Disorder and suicidal ideations, and beginning weekly monitoring within 1-2 weeks for worsening suicidality, alongside planning cognitive behavioral therapy focused on suicide prevention 1

Immediate Safety and Monitoring

  • The likelihood of dying by suicide in patients with MDD is 8.62 times higher than the general population, with the first year following hospital discharge representing the period of greatest risk 2, 3, 4

Pharmacological Management

  • Second-generation antidepressants should be selected based on adverse effect profiles rather than efficacy, as no single agent demonstrates superior effectiveness, according to the American College of Physicians 1
  • Bupropion has lower rates of sexual dysfunction compared to SSRIs, while paroxetine has higher rates than fluoxetine, fluvoxamine, or sertraline, as noted by the American College of Physicians 1
  • SSRIs are associated with increased suicide attempts compared to placebo, particularly in patients under age 25, as reported by the American College of Physicians 1

Psychotherapeutic Interventions

  • Cognitive behavioral therapy focused on suicide prevention demonstrates the strongest evidence for reducing suicide attempts in patients with recent suicidal behavior and decreasing suicidal ideation, according to the American College of Physicians 5
  • The American Psychological Association suggests that CBT should be added to pharmacotherapy as it reduces suicidal ideation, behavior, and hopelessness 6

Post-Discharge Planning

  • The American College of Physicians recommends continuing antidepressant treatment for 4-9 months after achieving satisfactory response in first-episode MDD 1
  • For patients with two or more depressive episodes, the American College of Physicians suggests extending treatment duration beyond 9 months 1
  • Implementing caring communications, such as brief, supportive postal mail or text messages, sent at regular intervals over 12 months post-discharge, reduces suicide attempts by 43%, as noted by the American College of Physicians 5
  • Women with MDD face 9.40 times higher odds of death by suicide compared to the general population, emphasizing the need for close monitoring, according to the American College of Physicians 3, 7

Common Pitfalls to Avoid

  • The American College of Physicians advises against prematurely discontinuing or switching antidepressants before completing adequate 6-8 week trials 1
  • Inadequate treatment duration is a modifiable risk factor for persistent suicidality, as reported by the American College of Physicians 1

Risk Stratification Considerations

  • The American College of Physicians suggests that clinical interviews should document medication adherence history, as part of risk stratification considerations 6
  • The duration of the current depressive episode is an important factor in risk stratification, according to the American College of Physicians 1
  • Social support availability is also a crucial factor in risk stratification, as noted by the American College of Physicians 3